A concise update on the relevance of secretory phospholipase a2 group iia and its inhibitors with cancer

Juan Chen, Long Ye, Yu Sun, Yoshikazhu Takada

Research output: Contribution to journalReview article

Abstract

Secretory phospholipase A2 group IIA (sPLA2-IIA) is an enzyme that hydrolyzes the sn-2 ester bond in glyceroacyl phospholipids present in lipoproteins and cell membranes. As many immunohistochemical studies reveal that the high expression of sPLA2-IIA in the tumorous tissue or plasma of cancer patients, though low expression in other cases, the enzyme is considered highly relevant with cancer development. Effort has been made to establish the mechanism of how sPLA2-IIA is involved in various cancers in order to understand its pathogenic role and to utilize it as a target for cancer diagnosis and therapy. This article specifically reviews recent studies regarding the relevance of sPLA2-IIA with various cancers and reported inhibitors of the protein.

Original languageEnglish (US)
Pages (from-to)606-615
Number of pages10
JournalMedicinal Chemistry
Volume13
Issue number7
DOIs
StatePublished - Jan 1 2017

Fingerprint

Secretory Phospholipase A2
Group II Phospholipases A2
Neoplasms
Enzymes
Lipoproteins
Phospholipids
Esters
Cell Membrane
Proteins

Keywords

  • Cancer incidence
  • Cell membranes
  • Inhibitors
  • Lipoproteins
  • sPLA-IIA
  • Therapeutic strategy.

ASJC Scopus subject areas

  • Drug Discovery

Cite this

A concise update on the relevance of secretory phospholipase a2 group iia and its inhibitors with cancer. / Chen, Juan; Ye, Long; Sun, Yu; Takada, Yoshikazhu.

In: Medicinal Chemistry, Vol. 13, No. 7, 01.01.2017, p. 606-615.

Research output: Contribution to journalReview article

@article{e5248435068741ac815cfc1791149939,
title = "A concise update on the relevance of secretory phospholipase a2 group iia and its inhibitors with cancer",
abstract = "Secretory phospholipase A2 group IIA (sPLA2-IIA) is an enzyme that hydrolyzes the sn-2 ester bond in glyceroacyl phospholipids present in lipoproteins and cell membranes. As many immunohistochemical studies reveal that the high expression of sPLA2-IIA in the tumorous tissue or plasma of cancer patients, though low expression in other cases, the enzyme is considered highly relevant with cancer development. Effort has been made to establish the mechanism of how sPLA2-IIA is involved in various cancers in order to understand its pathogenic role and to utilize it as a target for cancer diagnosis and therapy. This article specifically reviews recent studies regarding the relevance of sPLA2-IIA with various cancers and reported inhibitors of the protein.",
keywords = "Cancer incidence, Cell membranes, Inhibitors, Lipoproteins, sPLA-IIA, Therapeutic strategy.",
author = "Juan Chen and Long Ye and Yu Sun and Yoshikazhu Takada",
year = "2017",
month = "1",
day = "1",
doi = "10.2174/1573406413666170209121317",
language = "English (US)",
volume = "13",
pages = "606--615",
journal = "Medicinal Chemistry",
issn = "1573-4064",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - A concise update on the relevance of secretory phospholipase a2 group iia and its inhibitors with cancer

AU - Chen, Juan

AU - Ye, Long

AU - Sun, Yu

AU - Takada, Yoshikazhu

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Secretory phospholipase A2 group IIA (sPLA2-IIA) is an enzyme that hydrolyzes the sn-2 ester bond in glyceroacyl phospholipids present in lipoproteins and cell membranes. As many immunohistochemical studies reveal that the high expression of sPLA2-IIA in the tumorous tissue or plasma of cancer patients, though low expression in other cases, the enzyme is considered highly relevant with cancer development. Effort has been made to establish the mechanism of how sPLA2-IIA is involved in various cancers in order to understand its pathogenic role and to utilize it as a target for cancer diagnosis and therapy. This article specifically reviews recent studies regarding the relevance of sPLA2-IIA with various cancers and reported inhibitors of the protein.

AB - Secretory phospholipase A2 group IIA (sPLA2-IIA) is an enzyme that hydrolyzes the sn-2 ester bond in glyceroacyl phospholipids present in lipoproteins and cell membranes. As many immunohistochemical studies reveal that the high expression of sPLA2-IIA in the tumorous tissue or plasma of cancer patients, though low expression in other cases, the enzyme is considered highly relevant with cancer development. Effort has been made to establish the mechanism of how sPLA2-IIA is involved in various cancers in order to understand its pathogenic role and to utilize it as a target for cancer diagnosis and therapy. This article specifically reviews recent studies regarding the relevance of sPLA2-IIA with various cancers and reported inhibitors of the protein.

KW - Cancer incidence

KW - Cell membranes

KW - Inhibitors

KW - Lipoproteins

KW - sPLA-IIA

KW - Therapeutic strategy.

UR - http://www.scopus.com/inward/record.url?scp=85038130144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038130144&partnerID=8YFLogxK

U2 - 10.2174/1573406413666170209121317

DO - 10.2174/1573406413666170209121317

M3 - Review article

C2 - 28185537

AN - SCOPUS:85038130144

VL - 13

SP - 606

EP - 615

JO - Medicinal Chemistry

JF - Medicinal Chemistry

SN - 1573-4064

IS - 7

ER -